Patents by Inventor David Sattelle

David Sattelle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040224910
    Abstract: We describe the molecular and functional characterization of the C. elegans unc-63 gene, a levamisole resistance locus on chromosome I, which encodes a nicotinic acetylcholine receptor (nAChR) &agr; subunit. The derived amino acid sequence of UNC-63 most closely resembles that of UNC-38, the product of a separate levamisole resistance locus. Using a gfp::unc-63 fusion construct, expression has been detected in muscles (body wall, vulval) and motorneurons of C. elegans. Nuclear injection into Xenopus laevis oocytes of unc-63 cDNA together with lev-1 and unc-29 results in the expression for the first time of a robust functional C. elegans heteromeric nAChR. The EC50 for ACh of the expressed receptor (20 &mgr;M) resembles that of native nematode muscle nAChRs. Nicotine and the anthelmintic drug levamisole are agonists and mecamylamine is an antagonist of this expressed receptor.
    Type: Application
    Filed: December 7, 2001
    Publication date: November 11, 2004
    Inventors: David Sattelle, Emmanuel Culetto, Howard Baylis